Atlas Trials

Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy

Clinical trial NCT00754091 · COMPLETED

Trial details

NCT number
NCT00754091
Sponsor
Procter and Gamble
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2008-06-01
Primary completion
2008-06-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.